Siemens to build $433M man­u­fac­tur­ing plant in China

BioSpectrum (Asia) - - SUPPLIER NEWS -

Siemens Health­i­neers is set to in­vest $433 mil­lion to con­struct a new lab­o­ra­tory di­ag­nos­tics plant in Shang­hai, China. Siemens Health­i­neers has de­cided to ex­pand its ca­pac­ity in Shang­hai, based on Chi­nese gov­ern­ment de­ci­sion of open­ing its mar­ket of med­i­cal in­stru­ments to over­seas in­vestors.

The new lab­o­ra­tory di­ag­nos­tic plant is said to be the firm’s first in-vitro di­ag­nos­tic reagent plant in Asia Pa­cific, which will in­volve in the production of clin­i­cal chem­istry and im­munoas­say reagents. Siemens’ new in-vitro di­ag­nos­tic reagent plant will help cre­ate new 500 jobs in the re­gion.

Pre­vi­ously, Siemens Health­i­neers agreed to ac­quire Lux­em­bourg-based molec­u­lar di­ag­nos­tic tests sup­plier Fast Track Di­ag­nos­tics (FTD) for an undis­closed sum. FTD is en­gaged in the de­sign, de­vel­op­ment and man­u­fac­tur­ing of in­fec­tious dis­ease de­tec­tion kits. The com­pany pro­duces kits that can de­tect a range of viruses, bac­te­ria, fungi and par­a­sites.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.